Kinevant Sciences GmbH Report issue

For profit Phase 2
Founded: Basle-City Switzerland (2018)
Status: Acquired by Roivant Sciences, Inc. (2018)

Organization Overview

First Clinical Trial
2019
NCT04205851
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Kinevant Sciences GmbH